GDUFA III

[FDA]

On August 18, 2017, the President signed into law the Food and Drug Administration Reauthorization Act (FDARA), which includes the reauthorization of the Generic Drug User Fee Amendments (GDUFA) through September 2022.


Baca selengkapnya di : http://www.fda.gov...